A cute respiratory distress syndrome (ARDS) is characterized by an inflammatory response to lung injury (1) . The American-European Consensus Committee on ARDS (AECC) suggested that the type and severity of injury may affect the likelihood of developing the syndrome, but it remains unclear why up to 50% of individuals are not affected despite experiencing similar exposures (1, 2) . Genetic variation between individuals probably accounts for at least some of this observed heterogeneity. Variations in the genes encoding for a variety of proteins have been associated with the risk of developing or dying from ARDS. These proteins include myosin light chain kinase, angiotensin-converting enzyme, surfactant proteins, and some cytokines (3) (4) (5) (6) (7) (8) (9) .
Pre-B-cell colony-enhancing factor (PBEF) is a cytokine that was originally isolated in 1994 from a human lymphocyte DNA library (10) . The protein's function is not completely understood, but it has been implicated in pre-B-cell colony formation, normal and preterm labor, sepsis, colorectal cancer, obesity, and diabetes mellitus (11) (12) (13) (14) (15) (16) (17) . Recently, Ye and colleagues (18) demonstrated that PBEF gene expression is increased in human and animal models of acute lung injury (ALI) and that PBEF protein levels are increased in in vitro models of ALI and in serum and bronchoalveolar lavage fluid from humans and animals with ALI. In addition, those authors detected 11 single-nucleotide polymorphisms (SNPs) of the PBEF gene through resequencing. Genotyping of 271 subjects for two of these SNPs showed that the T-1001G variant allele (-1001G) was present more frequently in patients with sepsis and sepsis-associated ALI than in healthy controls, whereas the C-1543T variant allele (-1543T) was present less frequently in patients with sepsis-associated ALI than in healthy controls. However, no association was found between the PBEF polymorphisms and ALI compared with septic patients without ALI (18) . Thus, it is not clear whether the association between the PBEF polymorphism and ALI is due to its association with ALI or the underlying risk factor for ALI (sepsis). In addition, this study was not able to evaluate the effect of genotype on mortality, leaving open the question of whether these polymorphisms are also associated with altered severity of illness.
We sought to investigate the association between the T-1001G and C-1543T polymorphisms in the PBEF gene and the development of ARDS in a hospital-based, nested case-control study consisting of patients at risk for ARDS from septic and noninfectious insults. We hypothesized that the -1001G allele is associated with increased development of ARDS whereas the -1543T allele is associated with decreased development of ARDS.
METHODS
Study Enrollment and Design. Study design and exclusion criteria were described previously (5). Adult intensive care unit (ICU) admissions to the Massachusetts General Hospital (Boston, MA) from September 1999 to May 2005 were screened for risk factors for ARDS development (Table 1) . Eligible patients were approached and enrolled in the prospective cohort after informed written consent was obtained from subjects or surrogates. Study design is illustrated in Figure 1 . Patients were screened daily until death or ICU discharge and defined as having ARDS if they developed respiratory failure requiring intubation and met AECC criteria (1) for ARDS development. A nested case-control study was constructed using ARDS patients as cases and patients without ARDS as controls. The Massachusetts General Hospital Human Subjects Committee approved the study.
Genotyping. A 10-mL blood sample was collected from each patient in an ethylenediaminetetraacetic-acid tube. DNA was extracted using PureGene kits (Gentra Systems, Research Triangle, NC) and genotyped using 5' nuclease (Taqman) assays with custom primers and probes (Applied Biosystems, Foster City, CA). For T-1001G, the forward primer sequence was 5'-ACGGGCCAAGCCTTTGA-3', reverse primer sequence was 5'-CCAACTCGTTTCCCAGGATTTA-AAG-3', and reporter sequence was 5'-TCAGTG/ TTCGCACCCTG-3'. Corresponding C-1543T sequences were 5'-GCAAAGATCATGGAAGTG-GAAGGTA-3', 5'-CCTCGTTGCTGAAAATAATTG-TAAGTGT-3', and 5'-CACCAG/AGCACTCAC-3'.
Genotyping personnel were blinded to case-control status. Two separate readers interpreted results, and 5% of samples were randomly reanalyzed for quality control. No genotyping errors were found.
Statistical Analysis. Deviation from HardyWeinberg equilibrium (19) was determined using SAS Genetics software package (version 9.1, SAS Computing) PROC ALLELE test. Linkage disequilibrium was measured using Lewontin's D' in controls (20) . Univariate analysis was performed using chi-square tests for categorical variables and t-tests for continuous variables as appropriate. Variables with p Յ .2 were entered into a logistic-regression model using a backwardselection algorithm and eliminated if p Ͼ .2. The final model included gene effect; variables from backward elimination; significant interactions; clinically relevant variables such as age, gender, and ARDS risk factor; whether patients had received transfusion of blood products; and Acute Physiology and Chronic Health Evaluation (APACHE) III score. APACHE III scores were revised to remove PaO 2 /FIO 2 and age from the score to avoid colinearity in the model (21) . Likelihood ratio testing suggested that a dominant model of inheritance fit the data best.
Because existing data (18) focused on septic patients, we decided a priori to stratify analysis by patients with infectious and noninfectious risk factors to determine whether gene effects vary by risk factor.
Cox proportional hazards models were used for multivariate analysis of the effect of genotype Figure 1 . Schematic of patient selection and study design. *Excluded for prior enrollment or history of acute respiratory distress syndrome (ARDS) (each subject analyzed once, duplicate enrollment excluded) (n ϭ 97), genetic heritage other than white (n ϭ 99), failure of genotyping (n ϭ 10), or other reasons (n ϭ 8). ICU, intensive care unit. on all-cause ICU mortality as well as 28-day and 60-day mortality. The 28-day and 60-day analyses were restricted to patients with ARDS, because other patients were not followed after ICU discharge. Candidate variables were selected for inclusion into the model using a process similar to that described for the multivariable logistic regression model. The final proportional hazards model included covariates for gene effect, age, gender, APACHE III, severity of illness/organ dysfunction, and the presence of the ARDS risk factors sepsis, septic shock, or direct pulmonary injury. Covariates were tested to ensure they did not violate the proportional hazards assumption. All covariates complied with this assumption. Haplotypes were generated using SAS software and the Happy macro (http://www.hsph. harvard.edu/faculty/kraft/soft.htm), which infers haplotypes using an "expectation substitution" algorithm (22, 23) . This approach gives accurate estimates for common haplotypes (Ͼ4%) with moderate relative risks (24) . Haplotype scores were entered as covariates in the multivariable logistic regression model, again assuming dominant inheritance.
Assuming allele frequencies of 22% for -1001G, 25% for -1543T, ␣-error of .05, and 80% power, our sample (375 patients, 787 controls) could detect minimum odds ratios (ORs) for ARDS development of 1.43 for -1001G and 0.68 for -1543T. Analyzing sepsis patients (99 patients, 298 controls) would provide minimum 
RESULTS
Cohort Characteristics. From October 1999 to February 2005, 18,332 adult ICU admissions were screened for this study (Fig. 1) , and 1,376 patients were enrolled in the cohort. Patients with a genetic heritage other than white (n ϭ 99), patients who had been previously enrolled or had a history of ARDS (n ϭ 97), patients who could not be genotyped (n ϭ 10), and other patients (n ϭ 8) were excluded from analysis, leaving 1,162 patients in the final analysis, including 375 patients with ARDS and 787 controls.
Characteristics of the study population are shown in Table 2 . Data relevant to clinical risk factors for ARDS have been described previously and detailed (5) .
Genetic Analysis and Risk of ARDS. In all, 418 patients were heterozygous and 74 patients were homozygous for -1001G, with an allele frequency of 0.24. Meanwhile, 414 patients were heterozygous and 64 patients were homozygous for -1543T allele, with an allele frequency of 0.23. These genotype frequencies did not differ significantly from those predicted by Hardy-Weinberg equilibrium (p Ͼ . 25) and are comparable to the prior report (18) . Both polymorphisms were highly linked (Lewontin's D' ϭ 1.00).
Genotype and haplotype frequencies are presented in Table 3 . There was a significant difference in the proportion of cases and controls with regard to genotype at the T-1001G locus (p ϭ .05). Patients with ARDS were significantly more likely to have at least one copy of the variant allele compared with controls (178 of 375, or 47%, vs. 314 of 787, or 40%; p ϭ .02). ARDS patients were less likely to have one or more copies of the -1543T allele compared with controls (144 of 375, or 38%, vs. 334 of 787, or 42%), but this was not statistically significant (p ϭ .2). Of the four possible haplotypes, the GT haplotype (both variant alleles) was not observed in the study population.
Results of multivariable analysis are presented in Table 4 . Patients with the -1001G allele had greater odds of developing ARDS than wild-type homozygotes (OR adj , 1.35; 95% confidence interval [ (Table 5) To determine whether gene effect varied by ARDS risk factor, the association between the variant alleles and ARDS was examined further in the multivariable model after stratifying the population into groups of patients with sepsis, septic shock, or noninfectious (all other) risk factors for ARDS. Among the 397 patients with sepsis syndrome, the odds of developing ARDS were significantly increased by presence of -1001G (OR adj , 2.09; 95% CI, 1.23-3.56). Among the 561 patients with septic shock, the odds of developing ARDS for patients with -1543T (OR adj , 0.66; 95% CI, 0.45-0.97) were significantly decreased. For patients with noninfectious risk factors, the odds of developing ARDS were significantly increased with the presence of -1001G (OR adj , 2.3; 95% CI, 1.14 -4.72). The association between ARDS and -1001G was not statistically significant in the subgroup of patients with septic shock (p ϭ .55). Likewise, the association between ARDS and -1543T was not statistically significant in the subgroups of patients with either sepsis or noninfectious risk factors (p ϭ .53, p ϭ .74).
Exploratory analyses were conducted to explain why the association between -1001G allele and ARDS differed between sepsis and septic shock. First, the septic and septic shock groups were compared. Septic shock patients were significantly older (p Ͻ .0001), had higher APACHE III scores (p Ͻ .0001), were more likely to have received blood transfusions (p Ͻ .0001) or to have multiple risks for ARDS (p ϭ .05), and were more likely overall to develop ARDS (p Ͻ .0001). We hypothesized that effect modification by age or severity of illness might have resulted in dilution of the gene effect in this group of patients who appeared to be at highest risk of ARDS. To explore this, all patients were analyzed using the multivariable model after stratification by APACHE III score quartile. This revealed that the estimated odds ratios for the effect of -1001G on ARDS development decreased with increasing severity of illness (Fig. 2) , suggestive of an interaction between APACHE III score, -1001G allele, and ARDS. However, the results are not statistically significant, given the reduced sample size in each stratum. Analyzing age independently in this fashion did not reveal a similar interaction.
The results of Cox proportional hazards analyses are shown in Table 6 . The -1001G allele and the related GC haplotype were associated with significantly increased hazard of ICU mortality. When restricted to ARDS patients, the haplotype association remained significant; -1543T and the associated TT haplotype were significantly associated with 28-day and 60-day mortality in ARDS. The TT haplotype, but not the -1543T allele, was significantly associated with ARDS ICU mortality, as well.
Days of mechanical ventilation were recorded as a secondary outcome. ARDS patients with the -1543T allele had significantly more ventilator-free days 
DISCUSSION
Our results demonstrate an association between the variant T-1001G allele and related haplotype and increased risk of poor outcomes, as well as an apparently protective role for the variant C-1543T allele and related haplotype, in a case-control study of critically ill patients. This study design has a number of strengths. Using the AECC definition of ARDS (1) to prospectively identify cases helps minimize bias due to misclassification in the absence of a gold standard for diagnosis of this disease. As one of the largest studies reported on development of ARDS, this study has more power than other prior reports and allows us to examine gene-environment interactions via stratified analysis. The selection of patients with risk factors for ARDS as controls is preferable to using healthy controls, as healthy patients without a stimulus for lung injury would not be expected to develop ARDS based on genetic factors alone. Including heterogeneous risk factors for ARDS in both groups also minimizes confounding due to association of genotype with a single risk factor. Using only white patients in the analysis also reduces the possibility of confounding by population stratification, although this can still occur at a potentially significant level (25) .
However, only including whites also results in a potential limitation of the study, as the results cannot be extrapolated to other genetic heritages. Another potential limitation of the study is that the functional significance of these PBEF polymorphisms is not confirmed in the patient population. Also, because of the study design, the results cannot be generalized to the community-hospital setting, to immunocompromised patients, to patients without risk factors for ARDS, or to patients with different clinical risks for ARDS than those studied.
In the prior study by Ye and colleagues (18), frequencies of the -1001G allele and the associated haplotype were found to be increased in patients with sepsis and sepsisassociated ALI compared with healthy controls. Our study confirms and extends this finding by demonstrating that this allele and haplotype are also associated with increased susceptibility to ARDS among atrisk patients with both septic and nonseptic risk factors for ARDS. We also present the novel finding that the -1001G allele and GC haplotype are associated with ICU mortality in the entire population of at-risk patients and that the haplotype is also associated with ICU mortality among ARDS patients. In our study, the presence of either variant genotype was not shown to be associated with the presence or absence of sepsis syndrome or septic shock, decreasing the probability that association between the gene and development of a septic phenotype confounds association with ARDS development.
After stratification by risk factor for ARDS, the association between the variant -1001G allele and ARDS development was stronger in the group of patients with sepsis syndrome and those with noninfectious risk factors for ARDS. Also, the -1543T allele was found to be associated with ARDS development in the group of patients with septic shock but not in the larger patient population with sepsis syndrome and noninfectious risk factors for ARDS. It is unclear why the -1001G association was different in patients with septic shock compared with patients with sepsis syndrome. Our exploratory analyses suggest the presence of an interaction between -1001G and severity of illness whereby the effect of the variant on the development of ARDS decreases with the increasing severity of illness seen in septic shock. In addition, other factors that increase the risk of ARDS were present more frequently in the septic shock group. It is possible that among the most severely ill patients, the relative protective effect of the homozygous wild-type genotype is diminished by the greater nongenetic clinical risk factors for lung injury seen more frequently in septic shock. However, this interaction was found on post hoc exploratory analyses and likely did not have the power to draw meaningful conclusions. These findings will need to be confirmed and further studied in a larger population.
Ye and colleagues (18) found that the -1543T allele was present less frequently in patients with sepsis-associated ALI than healthy controls. In contrast, we did not find a significant difference in frequency of this allele or the related haplotype between cases and controls except among patients with septic shock. We attribute the difference in these findings to difference in selection of controls between the two studies. Indeed, Ye et al. (18) did not find any association between -1543T and development of ALI when compared with non-ALI sepsis patients. The protective effect of -1543T appears to be in opposition to the increased risk conferred by -1001G allele, and the two polymorphisms appear to exert influence in different subgroups of patients. This suggests the presence of complex geneenvironment interactions that should be studied further.
We also found that the -1001G allele is associated with increased ICU mortality, whereas the -1543T allele is associated with improved outcomes later in the course of ARDS, including 28-day and 60-day mortality, and fewer days of mechanical ventilation. In terms of biological rationale for the observed effects, it is known that PBEF expression is increased in response to inflammatory stimuli, such as in human fetal membranes in vitro and in vivo in response to mechanical distention and infection (15, 26) . In turn, PBEF increases expression of other inflammatory mediators, such as interleukin-6 and interleukin-8 (11) . Additional effects of PBEF include inducing de- lays in neutrophil apoptosis (17) and mediating pulmonary capillary permeability (14) , both of which processes are implicated in the pathogenesis of lung injury (11-14, 17, 27) . The -1543T allele is associated with decreased PBEF expression in vitro, and although the -1001G allele was not associated with altered expression levels, it is plausible that increased expression might account for its apparent opposing effect to -1543T. Given these data, it is possible to envision a process by which increased PBEF expression in response to inflammatory stimuli results in increased ARDS development and worse outcomes early in disease. It is less clear why the protective effect of -1543T emerges more strongly later in the disease process. One possibility is that this genotype enhances down-regulation of expression once the initial inflammatory insult has subsided. With regard to functional significance, because the T-1001G SNP is located in the promoter region of the gene (18) , variation in this SNP would not by itself result in the transcription of a different protein product but could alter the amount of protein expressed. In light of the findings by Ye and colleagues (18) that variation in this promoter polymorphism did not alter the level of PBEF expression in vitro, it is possible that this SNP serves as a marker for an as-yet unknown polymorphism within the gene with functional significance. Linkage disequilibrium with an external gene is also possible for either of the SNPs studied, but the chromosomal location of PBEF at 7q22 contains mainly genes that are not suspected of involvement in inflammatory processes, such as SYPL1 and PIK3CG.
CONCLUSIONS
In our cohort of critically ill patients with risk factors for ARDS, the variant allele of the T-1001G SNP in the PBEF gene and the related haplotype are associated with increased risk of developing ARDS. Stratification of the analysis by risk factor for ARDS points to a potential gene-environment interaction between this gene, sepsis syndrome vs. septic shock as the risk factor for ARDS, and APACHE III score. The variant C-1543T allele of the PBEF gene was found to be associated with decreased risk of developing ARDS among the subgroup of patients with septic shock. In addition, the variant T-1001G allele and related haplotype are associated with increased ICU mortality, whereas the variant C-1543T allele and related haplotype are associated with decreased 28-day and 60-day mortality and fewer days of mechanical ventilation. Further study is warranted to determine the pathophysiologic and genetic bases of these associations.
